Association of Diabetes Mellitus With Health Status Outcomes in Patients With Peripheral Artery Disease: Insights From the PORTRAIT Registry.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
17 11 2020
Historique:
pubmed: 7 11 2020
medline: 2 4 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

Background Patients with peripheral artery disease (PAD) and coexisting diabetes mellitus (DM) have greater PAD progression and adverse limb events. Our aim was to study whether PAD-specific health status differs by DM. Methods and Results The PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories) trial is a 16-center international registry that includes patients with recent exacerbations or new-onset symptomatic PAD presenting to specialty clinics. We assessed PAD-specific health status initially and at 3, 6, and 12 months (Peripheral Artery Questionnaire [PAQ]). We used hierarchical, multivariable, linear regression, and repeated measures analyses to study the association between DM and baseline health status initially and over 3 to 12 months. Models were adjusted for demographics, socioeconomic factors, PAD severity, comorbidities, and psychosocial characteristics. The interaction of DM with PAD revascularization on 3- to 12-month health status was also tested. Of 1204 patients, 398 (33%) had DM (94% type 2). Patients with versus those without DM had lower unadjusted PAQ summary scores at baseline and 3, 6, and 12 months (46.1 versus 50.8, 63.6 versus 68.2, 65.7 versus 71.7, and 65.4 versus 72.6;

Identifiants

pubmed: 33153398
doi: 10.1161/JAHA.120.017103
pmc: PMC7763706
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e017103

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL110837
Pays : United States

Références

Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Vasc Surg. 2001 Dec;34(6):962-70
pubmed: 11743546
World J Diabetes. 2015 Jul 10;6(7):961-9
pubmed: 26185603
Am J Epidemiol. 2001 Apr 1;153(7):666-72
pubmed: 11282794
Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e003860
pubmed: 29440123
J Vasc Nurs. 2005 Jun;23(2):61-6; quiz 67-8
pubmed: 16102474
Eur J Vasc Endovasc Surg. 2008 Jul;36(1):63-70
pubmed: 18356087
Vasc Med. 2014 Jun 17;19(4):307-314
pubmed: 24939930
Lancet. 2013 Oct 19;382(9901):1329-40
pubmed: 23915883
J Am Heart Assoc. 2020 Nov 17;9(22):e017103
pubmed: 33153398
Eur J Vasc Endovasc Surg. 2014 Oct;48(4):447-51
pubmed: 25116276
Atherosclerosis. 2005 Jun;180(2):389-97
pubmed: 15910867
Acta Med Scand. 1985;218(2):217-21
pubmed: 4061125
J Vasc Surg. 2007 Apr;45(4):751-61
pubmed: 17306950
Am Heart J. 2004 Feb;147(2):301-8
pubmed: 14760329
Diabetol Metab Syndr. 2014 Feb 17;6(1):21
pubmed: 24533798
Ann Vasc Surg. 2008 May-Jun;22(3):481-91
pubmed: 18411027
Diabetes Care. 2001 Aug;24(8):1433-7
pubmed: 11473082
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
J Cardiopulm Rehabil. 2003 Nov-Dec;23(6):398-403
pubmed: 14646785
Circulation. 1997 Jul 1;96(1):44-9
pubmed: 9236415
Geriatr Gerontol Int. 2013 Apr;13(2):443-50
pubmed: 22934536
Diabetes Care. 2003 Dec;26(12):3333-41
pubmed: 14633825
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Diabetes Care. 2002 Jan;25(1):113-20
pubmed: 11772911
J Diabetes. 2017 Feb;9(2):133-140
pubmed: 27556728
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Vasc Surg. 2017 Feb;65(2):414-421.e5
pubmed: 27667149
Eur Heart J. 2013 Aug;34(31):2444-52
pubmed: 23625211
Circulation. 2012 Jan 3;125(1):130-9
pubmed: 22090168
J Am Coll Cardiol. 2006 Mar 7;47(5):921-9
pubmed: 16516072

Auteurs

Krishna K Patel (KK)

University of Missouri-Kansas City Kansas City MO.
Saint Luke's Mid America Heart Institute Kansas City MO.

Hani Alturkmani (H)

University of Missouri-Kansas City Kansas City MO.
Truman Medical Centers Kansas City MO.

Kensey Gosch (K)

Saint Luke's Mid America Heart Institute Kansas City MO.

Carlos Mena-Hurtado (C)

Yale School of Medicine New Haven CT.

Mehdi H Shishehbor (MH)

University Hospital Cleveland Medical Center and Case Western Reserve University School of Medicine Cleveland OH.

Poghni A Peri-Okonny (PA)

University of Missouri-Kansas City Kansas City MO.
Saint Luke's Mid America Heart Institute Kansas City MO.

Mark A Creager (MA)

Dartmouth-Hitchcock Heart and Vascular Center Lebanon NH.

John A Spertus (JA)

University of Missouri-Kansas City Kansas City MO.
Saint Luke's Mid America Heart Institute Kansas City MO.

Kim G Smolderen (KG)

University of Missouri-Kansas City Kansas City MO.
Saint Luke's Mid America Heart Institute Kansas City MO.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH